Search Results 11-20 of 16232 for what is vedolizumab

  1. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...

  2. Vedolizumab (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

    Pediatric. Appropriate studies have not been performed on the relationship of age to the effects of vedolizumab injection in the pediatric population. Safety ...

  3. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used as a maintenance treatment for moderate to severe active Crohn's disease and ulcerative colitis after receiving an infliximab medicine given by ...

  4. Crohn's Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...

  5. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in ...

  6. Infliximab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who have ...

  7. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active ...

  8. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    ... Ulcerative Colitis (UC) or Crohn's Disease (CD) ... The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in ...

  9. Budesonide (Oral Route) Description and Brand Names - Mayo Clinic

    Budesonide is used to treat mild to moderate active Crohn's disease, an inflammatory bowel disease. This medicine works inside the intestines (bowels) to ...

  10. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    ... vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative colitis (UC) and Crohn's disease (CD). Participation eligibility. Participant ...